Thu, Aug 21, 2014, 11:10 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

IntelliCell BioSciences, Inc. Message Board

  • anyname_willdo anyname_willdo Jun 21, 2013 12:41 PM Flag

    MERCK subsidiary Millipore collaborating with Intellicell Biosciences. SVFC

    Check this out..MERCK subsidiary Millipore collaborating with Intellicell Biosciences..Millipore(American Subsidiary of MERCK)has executed an exclusive supply and sale agreement with IntelliCell BioSciences to sell and distribute the guava flow cytometry platform into the area of SVF..

    Quote:Another extremely important piece of information brought out in Gene Marcial’s Forbes article is that Millipore, the American-based subsidiary of the large pharmaceutical company, Merck AG of Germany, has studied IntelliCell’s technology and “confirmed that it produced an average of 10 times the number of SVF cells containing adult adipose stem cells from less than which the company believes is used by any of its competitor companies – that use enzymes in their process. The study also showed that the SVF cells produced by IntelliCell contain all the viable cells that are manufactured by competing technologies that use enzymes, such as Cytori.
    Subsequently, Marketwire reported that Millipore Corporation “a global leader in innovative tools and technologies for bio-manufacturing and life science research, has executed an exclusive supply and sale agreement with IntelliCell BioSciences to sell and distribute the guava flow cytometry platform into the area of SVF. This collaboration will streamline the development of IntelliCell’s tissue processing centers in the United States as it continues to expand and experience growth in demand for the cells it is able to source from fatty tissue.”
    Said Dr. Steven Victor, Founder and CEO of IntelliCell, “This is a phenomenal step in the right direction for our company, and we welcome the opportunity to work with Millipore. The exclusive agreement with Millipore to sell their cutting-edge guava flow cytometer, combined with our proprietary process, which has achieved unprecedented yields of stromal vascular fraction without the use of chemical additives such as enzymes, gives us a highly significant advantage in creating the gold standard for

 
SVFC
0.0013+0.0001(+8.33%)Aug 21 3:38 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.